Core A: Administrative Core
Core A: Administrative Core
批准号:
10203851
负责人:
Roy S Herbst
金额:
$15.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-08-26 至 2025-07-31
关键词:
AchievementAdvocacyAdvocateBasic ScienceCancer BiologyClinicalClinical ResearchCollaborationsCommunicationConflict (Psychology)ConsultationsDataDevelopmentDisputesEnsureEvaluationFoundationsFundingFutureGoalsGovernmentGrantHuman ResourcesHuman Subject ResearchInfrastructureInstitutionLaboratory FindingLeadershipMalignant neoplasm of lungMonitorNational Cancer InstituteOccupational activity of managing financesPatientsPhilanthropic FundPreparationPrincipal InvestigatorPrivatizationProgram EvaluationProgress ReportsPublicationsRegulationResearchResearch PersonnelResearch PriorityResourcesSeriesSourceTimeTimeLineTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesYale Cancer Centeranticancer researchcareercost effectivemeetingsneoplasm resourcenoveloperationoutreachpersonalized medicineprogramssuccesssymposiumtranslational cancer researchwebsite development
中文摘要
核心摘要
行政核心(核心A)由耶鲁大学肺部孢子首席研究员罗伊·赫布斯特执导
癌症(YSILC),由埃德·卡夫坦联合执导,得到了项目财务管理团队的支持。
行政核心的仔细监督将是确保耶鲁大学孢子在肺的成功的关键
癌症。核心A是YCC研究管理局提供的现有基础设施的扩展,以支持
并促进跨学科的研究工作。行政核心是中心协调
YSILC所有调查员的重点,负责监测所有项目和核心的进展情况
转换/临床终点。核心主任、联席主任与YISLC联席主任(陈博士)
负责领导YSILC计划,设定翻译研究的优先事项,确定新的
来自新兴数据的转换研究机会,监控所有项目、核心和
发展项目和确定项目、核心和翻译研究方向的变化,如
需要的。YSILC调查人员之间的互动由Core A促进,以加速翻译
将实验室结果纳入拟议和未来的临床研究。如果需要,核心A总监将管理
YSILC调查人员之间的冲突。作为一个团队,核心人员监控财务,维护
项目和核心领导之间的沟通,协调会议,包括每周肺癌
翻译小组研讨会系列、执行委员会每月会议、
内部/外部咨询委员会和一年一度的YSILC SEP和DRP研讨会。除了这些之外,
功能,核心是与NCI、其他肺癌孢子、耶鲁癌症中心和
耶鲁大学,并协调外联工作,包括出版物(内部和外部),网站
开发、研讨会、患者/研究倡导活动和筹款计划。通过这些
行政活动,核心A对YSILC计划的组织至关重要,对制定
耶鲁大学广泛培养的肺癌基础/临床/转化性研究及其高效成果
所述的计划目标,最终目标是对肺部疾病患者产生重大的临床影响
癌症。
英文摘要
CORE SUMMARY
The Administrative Core (Core A) is directed by Roy Herbst, Principal Investigator of the Yale SPORE in Lung
Cancer (YSILC), and co-directed by Ed Kaftan, with support from the program financial management team.
Careful oversight by the Administrative Core will be critical to ensure the success of the Yale SPORE in Lung
Cancer. Core A is an extension of existing infrastructure provided by YCC Research Administration to support
and facilitate transdisciplinary research efforts. The Administrative Core serves as the central coordination
point for all YSILC investigators, with responsibility for monitoring the progress of all projects and cores toward
a translational/clinical endpoint. The Core Director and Co-Director along with the YISLC Co-PI (Dr. Chen)
have responsibility for leading the YSILC program, setting translational research priorities, identifying new
translational research opportunities from emerging data, monitoring the progress of all projects, cores and
developmental projects and determining changes in direction of projects, cores and translational research as
needed. Interactions among YSILC investigators is facilitated by Core A to accelerate the translation of
laboratory findings into the proposed and future clinical studies. If required, the Core A Director will manage
conflicts among YSILC investigators. As a team, the Core personnel monitors finances, maintains
communications among project and core leaders and coordinates meetings, including the weekly lung cancer
translational group seminar series, monthly meetings of the Executive Committee, annual meetings of the
Internal/External Advisory boards and the annual YSILC SEP and DRP Symposium. In addition to these
functions, the Core is the primary interface with the NCI, other lung cancer SPOREs, Yale Cancer Center and
Yale University, and coordinates outreach efforts, including publications (internal and external), website
development, seminars, patient/research advocacy activities, and fundraising programs. Through these
administrative activities, Core A is essential to the organization of the YSILC program, to developing a
widespread culture of lung cancer basic/clinical/translational research at Yale and to the efficient achievement
of the stated program objectives, with the ultimate goal of a significant clinical impact for patients with lung
cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Yale Cancer Center NCTN LAPS
-
批准号:10359158
-
项目类别:
-
资助金额:$48.49万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale Cancer Center NCTN LAPS
-
批准号:10582614
-
项目类别:
-
资助金额:$87.91万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale Cancer Center NCTN LAPS
-
批准号:10734497
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:10203850
-
项目类别:
-
资助金额:$200.37万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer Developmental Research Program
-
批准号:10203857
-
项目类别:
-
资助金额:$8.96万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:9767058
-
项目类别:
-
资助金额:$213.48万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:9338869
-
项目类别:
-
资助金额:$71.51万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:8931829
-
项目类别:
-
资助金额:$218.5万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Administrative Core
-
批准号:8931832
-
项目类别:
-
资助金额:$86.07万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma
-
批准号:9379210
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8920514
-
项目类别:
-
资助金额:$55.45万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8707401
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8517039
-
项目类别:
-
资助金额:$52.79万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8332772
-
项目类别:
-
资助金额:$56.49万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8186504
-
项目类别:
-
资助金额:$58.43万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
U10 Ful Member Application Affiliated with SWOG
-
批准号:7555078
-
项目类别:
-
资助金额:$21.59万
-
财政年份:2004
-
负责人:Roy S Herbst
-
依托单位:
U10 Full Member Application Affiliated with SWOG
-
批准号:7767468
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2004
-
负责人:Roy S Herbst
-
依托单位:
Phase I trial of antiangiogenic agent SU6668 in Pt w solid tumors
-
批准号:6563965
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2002
-
负责人:Roy S Herbst
-
依托单位:
Core--Clinical trials
-
批准号:6563968
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2002
-
负责人:Roy S Herbst
-
依托单位:
Core--Clinical trials
-
批准号:6499818
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2001
-
负责人:Roy S Herbst
-
依托单位:
海外基金